The rapid and simultaneous delivery of bioactive compounds to a large population has long been considered essential for the prevention and control of disease outbreaks.

With PerOs' Oralject™, it is possible to perform mass inoculation by delivering a wide range of medicines orally through a single feeding.

With no needles or injection specialists required, Oralject™ provides a simple and cost-effective large scale solution to treat a variety of monogastric animals namely fish, shrimp, swine, poultry and companion animals.

The potential applications of the oralject™ technology are limitless. Our primary focus is to develop applications for the livestock industries in order to optimize production efficiency.

PerOs will focus initially on the Animal Health markets, namely the farming of fish and shrimp (aquaculture), poultry and swine. The world Animal Health and nutrition market is currently valued at US$ 15 billion . However, the demonstration by PerOs of the effectiveness of the Oralject system in the delivery of bioactive payloads in multiple species raises the possibility for the treatment of human disease. PerOs plans to establish a subsidiary to explore Oralject applications for the $19 billion human vaccine market .

PerOs’ current business model is to produce and sell its proprietary Oralject applications to regional and multinational animal producers, pharmaceutical companies, veterinary service organizations and certain fully integrated distributors.